AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23943282 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.4 % glyceryl trinitrate (GTN) ointment
Number of subjects: 104
Study 22504093 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept 30 mg/kg
Number of subjects: 451
Study 22504093 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept 10 mg/kg
Number of subjects: 451
Study 22504093 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept 3 mg/kg
Number of subjects: 451
Study 22504093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 451
Study 22504093 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 451
Study 20140448 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (dry needling) for 10 min
Number of subjects: 9
Study 20140448 — intervention group
Group type: EXPERIMENTAL
Intervention: Heating (application of hot pack) for 10 min
Number of subjects: 9
Study 19796735 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose statin therapy initiated pre-discharge
Number of subjects: 0
Study 19796735 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose statin therapy
Number of subjects: 0
Study 16435697 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-talker AV configurations with zero, one, or two channels of visual information combined with zero, one, or two channels of audio information.
Number of subjects: 0
Study 16435697 — intervention group
Group type: COMPARATOR
Intervention: Visual representation of only a single talker.
Number of subjects: 0
Study 12915639 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% protein diet
Number of subjects: 0
Study 12915639 — intervention group
Group type: COMPARATOR
Intervention: 15% protein diet
Number of subjects: 0
Study 10482346 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep deprivation (three cycles)
Number of subjects: 206
Study 8790125 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized ribavirin
Number of subjects: 8
Study 2006775 — intervention group
Group type: EXPERIMENTAL
Intervention: PuriDyne units with active filters
Number of subjects: 12
Study 2006775 — intervention group
Group type: COMPARATOR
Intervention: Units with inactive filters
Number of subjects: 12
Study 7048859 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic anterior capsulotomy
Number of subjects: 4
Study 7048859 — intervention group
Group type: EXPERIMENTAL
Intervention: Cingulotomy
Number of subjects: 4
Study 31949092 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulated eye drop with Leptospermum spp honey
Number of subjects: 46
Study 31949092 — intervention group
Group type: COMPARATOR
Intervention: Control eye drops (Alcon, USA)
Number of subjects: 46
Study 29890670 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved outer packaging
Number of subjects: 1149
Study 29890670 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved outer packaging combined with cooking demonstrations
Number of subjects: 1149
Study 29890670 — intervention group
Group type: COMPARATOR
Intervention: Original outer packaging
Number of subjects: 1149
Study 27611753 — intervention group
Group type: EXPERIMENTAL
Intervention: Symmetric natural functional tooth units
Number of subjects: 0
Study 27611753 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymmetric artificial functional tooth units
Number of subjects: 0
Study 25190442 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovoid/Spheroid shape
Number of subjects: 1679
Study 25190442 — intervention group
Group type: EXPERIMENTAL
Intervention: Slab shape
Number of subjects: 1679
Study 25190442 — intervention group
Group type: EXPERIMENTAL
Intervention: Stick shape
Number of subjects: 1679
Study 25190442 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent shape
Number of subjects: 1679
Study 25190442 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 1679
Study 25190442 — intervention group
Group type: EXPERIMENTAL
Intervention: Infarct volume
Number of subjects: 1679
Study 25190442 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular risk factors
Number of subjects: 1679
Study 22413944 — intervention group
Group type: EXPERIMENTAL
Intervention: CZP 200 mg
Number of subjects: 176
Study 22413944 — intervention group
Group type: EXPERIMENTAL
Intervention: CZP 400 mg
Number of subjects: 176
Study 22413944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study 20391072 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) program, 6-week duration
Number of subjects: 69
Study 20391072 — intervention group
Group type: COMPARATOR
Intervention: Educational control group
Number of subjects: 69
Study 18853940 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable monitoring (PM) and unattended autotitrating positive airway pressure (APAP)
Number of subjects: 106
Study 18853940 — intervention group
Group type: COMPARATOR
Intervention: Polysomnography (PSG)
Number of subjects: 106
Study 16471103 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine
Number of subjects: 61
Study 16471103 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine
Number of subjects: 61
Study 12579144 — intervention group
Group type: EXPERIMENTAL
Intervention: Open scaphocapitate fusion and lunate revascularization
Number of subjects: 16
Study 12579144 — intervention group
Group type: COMPARATOR
Intervention: Fully arthroscopic scaphocapitate fusion and capitate pole excision
Number of subjects: 16
Study 12579144 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study 10912689 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronan-based biomembrane
Number of subjects: 60
Study 10912689 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 60
Study 9295487 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 60
Study 9295487 — intervention group
Group type: COMPARATOR
Intervention: Ergotocin
Number of subjects: 60
Study 1906746 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic administration of OKT3
Number of subjects: 0
Study 6824997 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncal vagotomy and pyloroplasty (TVP)
Number of subjects: 153
Study 6824997 — intervention group
Group type: COMPARATOR
Intervention: Highly selective vagotomy (HSV)
Number of subjects: 153
Study 30890115 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute stenting of the cervical internal carotid artery
Number of subjects: 162
Study 30890115 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (no specific control intervention mentioned)
Number of subjects: 162
Study 30890115 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (no specific intervention mentioned)
Number of subjects: 162
Study 29170901 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy
Number of subjects: 160
Study 29170901 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Training (EXT)
Number of subjects: 160
Study 29170901 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (Phototherapy + EXT)
Number of subjects: 160
Study 29170901 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 160
Study 28199697 — intervention group
Group type: EXPERIMENTAL
Intervention: Early adenotonsillectomy (eAT)
Number of subjects: 380
Study 28199697 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting with supportive care (WWSC)
Number of subjects: 380
Study 26561614 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric low glycemic index (LGI) diet
Number of subjects: 26
Study 26561614 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study 23694840 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1000 IU/d)
Number of subjects: 116
Study 23694840 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 21508724 — intervention group
Group type: EXPERIMENTAL
Intervention: Plate fixation (group I, n=5)
Number of subjects: 15
Study 21508724 — intervention group
Group type: COMPARATOR
Intervention: Double screw technique (group II)
Number of subjects: 15
Study 21508724 — intervention group
Group type: COMPARATOR
Intervention: Single screw technique (group III)
Number of subjects: 15
Study 18245544 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine
Number of subjects: 54
Study 17106146 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy internal cardioversion (ICV)
Number of subjects: 52
Study 17106146 — intervention group
Group type: COMPARATOR
Intervention: Transthoracic cardioversion (TT CV)
Number of subjects: 52
Study 12574925 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic colectomy
Number of subjects: 59
Study 12574925 — intervention group
Group type: COMPARATOR
Intervention: Open colectomy
Number of subjects: 59
Study 11115196 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudoephedrine and acetaminophen
Number of subjects: 430
Study 11115196 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 430
Study 9337598 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed behavioral family intervention (SD)
Number of subjects: 24
Study 9337598 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (WL)
Number of subjects: 24
Study 8384658 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg once a day for 3 days)
Number of subjects: 51
Study 8384658 — intervention group
Group type: COMPARATOR
Intervention: Roxithromycin (150 mg every 12 hours for 7 days)
Number of subjects: 51
Study 3485028 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 98
Study 3485028 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 98
Study 29402234 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured follow-up by a GP and home care oncology nurse (HON) including a GP consultation before treatment and a minimum of three contacts with the HON during and after treatment.
Number of subjects: 150
Study 29402234 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured follow-up by a GP and home care oncology nurse (HON).
Number of subjects: 150
Study 29402234 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group).
Number of subjects: 150
Study 27797983 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentax Airway Scope (PAWS)
Number of subjects: 35
Study 27797983 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope video laryngoscope (GVL)
Number of subjects: 35
Study 27797983 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct laryngoscopy (DL)
Number of subjects: 35
Study 27797983 — intervention group
Group type: COMPARATOR
Intervention: Control group not applicable
Number of subjects: 35
Study 27543065 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong/Tai Chi Easy (QG/TCE)
Number of subjects: 250
Study 27543065 — intervention group
Group type: COMPARATOR
Intervention: Sham Qigong group (SQG)
Number of subjects: 250
Study 27543065 — intervention group
Group type: COMPARATOR
Intervention: Educational support (ES) group
Number of subjects: 250
Study 27543065 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarkers of HPA axis dysregulation (diurnal cortisol)
Number of subjects: 250
Study 27543065 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarkers of inflammation (IL1ra, IL6, TNFα and INFᵧ)
Number of subjects: 250
Study 22546175 — intervention group
Group type: EXPERIMENTAL
Intervention: Wood smoke exposure at 200 μg/m(3)
Number of subjects: 20
Study 22546175 — intervention group
Group type: EXPERIMENTAL
Intervention: Wood smoke exposure at 400 μg/m(3)
Number of subjects: 20
Study 22546175 — intervention group
Group type: COMPARATOR
Intervention: Clean air (control) exposure
Number of subjects: 20
Study 22546175 — intervention group
Group type: EXPERIMENTAL
Intervention: Wood smoke exposure (all concentrations)
Number of subjects: 20
Study 21330817 — intervention group
Group type: EXPERIMENTAL
Intervention: Line-of-Sight
Number of subjects: 150
Study 21330817 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline & Flicker
Number of subjects: 150
Study 21330817 — intervention group
Group type: EXPERIMENTAL
Intervention: Line-of-Sight & Flicker
Number of subjects: 150
Study 21330817 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning Sign
Number of subjects: 150
Study 21330817 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 150
Study 18448442 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625‐mg conjugated equine estrogens (CEEs)
Number of subjects: 0
Study 18448442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18448442 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined analyses of clinical trial and observational study data
Number of subjects: 0
Study 16204446 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychophysiologically oriented intervention (7 sessions plus 2 assessment sessions)
Number of subjects: 43
Study 16204446 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 43
Study 14527532 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal Exposure (IE)
Number of subjects: 82
Study 14527532 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-Imaginal Exposure (AI)
Number of subjects: 82
Study 14527532 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated In Vivo Exposure (IV)
Number of subjects: 82
Study 10327090 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger and heavier beds (single, double, king) at heights of 460 mm and 560 mm
Number of subjects: 0
Study 10327090 — intervention group
Group type: COMPARATOR
Intervention: Static models of lifting
Number of subjects: 0
Study 8959573 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration (GTR) with nonresorbable membranes
Number of subjects: 50
Study 8959573 — intervention group
Group type: COMPARATOR
Intervention: Mucogingival surgery (coronally-positioned free gingival graft)
Number of subjects: 50
Study 1756286 — intervention group
Group type: EXPERIMENTAL
Intervention: Otilonium bromide (OB)
Number of subjects: 40
Study 1756286 — intervention group
Group type: COMPARATOR
Intervention: Pinaverium bromide
Number of subjects: 40
Study 7386802 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified allergen preparation
Number of subjects: 40
Study 7386802 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude aqueous extract
Number of subjects: 40
Study 7386802 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 7386802 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 31686430 — intervention group
Group type: EXPERIMENTAL
Intervention: IOP of 15 mmHg (Group I: 32 eyes)
Number of subjects: 95
Study 31686430 — intervention group
Group type: EXPERIMENTAL
Intervention: IOP of 25 mmHg (Group II: 32 eyes)
Number of subjects: 95
Study 31686430 — intervention group
Group type: EXPERIMENTAL
Intervention: IOP of 35 mmHg (Group III: 31 eyes)
Number of subjects: 95
Study 31686430 — intervention group
Group type: COMPARATOR
Intervention: Comparison of groups
Number of subjects: 95
Study 30392140 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiet Eye training group (QET)
Number of subjects: 18
Study 30392140 — intervention group
Group type: COMPARATOR
Intervention: Control training group (CT)
Number of subjects: 18
Study 28571271 — intervention group
Group type: COMPARATOR
Intervention: 0.1% triamcinolone acetonide oral paste thrice daily in tapering doses
Number of subjects: 75
Study 28571271 — intervention group
Group type: EXPERIMENTAL
Intervention: curcumin oral gel thrice daily
Number of subjects: 75
Study 28571271 — intervention group
Group type: EXPERIMENTAL
Intervention: curcumin oral gel six times daily
Number of subjects: 75
Study 26451088 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic preparation inVag(®) administered vaginally for seven consecutive days
Number of subjects: 160
Study 26451088 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered vaginally for seven consecutive days
Number of subjects: 160
Study 23339578 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5 g of larch arabinogalactan preparation (n=101)
Number of subjects: 199
Study 23339578 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=98)
Number of subjects: 199
Study 18065335 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5 kg sandbag for 30 minutes with position change every hour
Number of subjects: 169
Study 18065335 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.3 kg sandbag for 2 hours with position change every hour
Number of subjects: 169
Study 18065335 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5 kg sandbag for 30 minutes without position change
Number of subjects: 169
Study 18065335 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.3 kg sandbag for 2 hours without position change
Number of subjects: 169
Study 18065335 — intervention group
Group type: COMPARATOR
Intervention: No sandbag and no position change (Control Group)
Number of subjects: 169
Study 14965858 — intervention group
Group type: COMPARATOR
Intervention: Principal Component Analysis (PCA) applied on multichannel magnetocardiographic (MCG) recordings in patients with MI.
Number of subjects: 44
Study 14965858 — intervention group
Group type: COMPARATOR
Intervention: Principal Component Analysis (PCA) applied on multichannel magnetocardiographic (MCG) recordings in patients with VT.
Number of subjects: 44
Study 14965858 — intervention group
Group type: COMPARATOR
Intervention: Principal Component Analysis (PCA) applied on multichannel magnetocardiographic (MCG) recordings in normals.
Number of subjects: 44
Study 14965858 — intervention group
Group type: COMPARATOR
Intervention: Principal Component Analysis (PCA) applied on multichannel magnetocardiographic (MCG) recordings in patients with CHD.
Number of subjects: 44
Study 11001237 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed regimen of 30 mg mirtazapine at bedtime
Number of subjects: 140
Study 11001237 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascending dose regimen of mirtazapine (15 mg to 30 mg at bedtime)
Number of subjects: 140
Study 11001237 — intervention group
Group type: COMPARATOR
Intervention: Both regimens (fixed and ascending dosing)
Number of subjects: 140
Study 9071932 — intervention group
Group type: EXPERIMENTAL
Intervention: bFGF 0.1 mg twice daily
Number of subjects: 12
Study 9071932 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg twice daily
Number of subjects: 12
Study 9071932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8326680 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin (OFLX) for 5 days
Number of subjects: 110
Study 8326680 — intervention group
Group type: COMPARATOR
Intervention: Ofloxacin (OFLX) for 10 days
Number of subjects: 110
Study 8326680 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin (OFLX) for both groups
Number of subjects: 110
Study 3098498 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel 20 mcg/day
Number of subjects: 110
Study 3098498 — intervention group
Group type: EXPERIMENTAL
Intervention: TCu 380 Ag IUD
Number of subjects: 110
Study 31129581 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengths Model Case Management (SMCM)
Number of subjects: 210
Study 31129581 — intervention group
Group type: COMPARATOR
Intervention: SMILE (control)
Number of subjects: 210
Study 29912624 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic warning labels
Number of subjects: 0
Study 29912624 — intervention group
Group type: COMPARATOR
Intervention: Text warning labels, calorie labels, and no labels
Number of subjects: 0
Study 27825381 — intervention group
Group type: EXPERIMENTAL
Intervention: Cornerstone program (case management, trauma-focused cognitive behavioral therapy, mentoring/peer support, community-based practice, stigma and skill development)
Number of subjects: 60
Study 27825381 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 60
Study 24911076 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosimilar G-CSF (Zarzio(®), Sandoz Biopharmaceuticals)
Number of subjects: 108
Study 24911076 — intervention group
Group type: COMPARATOR
Intervention: Originator G-CSF (Neupogen(®), Amgen)
Number of subjects: 108
Study 23158715 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral endotracheal intubation (OEI)
Number of subjects: 61
Study 23158715 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous dilatational tracheostomy (PDT)
Number of subjects: 61
Study 19619073 — intervention group
Group type: COMPARATOR
Intervention: Rivastigmine (transdermal patch)
Number of subjects: 0
Study 19619073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17178634 — intervention group
Group type: EXPERIMENTAL
Intervention: (R)-OXY
Number of subjects: 0
Study 17178634 — intervention group
Group type: EXPERIMENTAL
Intervention: (R)-DEOB
Number of subjects: 0
Study 17178634 — intervention group
Group type: EXPERIMENTAL
Intervention: (R)-OXY and (S)-OXY
Number of subjects: 0
Study 17178634 — intervention group
Group type: COMPARATOR
Intervention: OXY
Number of subjects: 0
Study 15711943 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrostimulation voice exercise
Number of subjects: 24
Study 15711943 — intervention group
Group type: COMPARATOR
Intervention: Traditional voice treatment
Number of subjects: 24
Study 12161090 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 180
Study 12161090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 9449870 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine 6 mg/kg
Number of subjects: 2534
Study 9449870 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine 6 mg/kg plus ivermectin 400 micrograms/kg
Number of subjects: 2534
Study 7887382 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg/day)
Number of subjects: 14
Study 7887382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 2240629 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide (N2O)
Number of subjects: 70
Study 2240629 — intervention group
Group type: COMPARATOR
Intervention: Oxygen with isoflurane
Number of subjects: 70
Study 360921 — intervention group
Group type: EXPERIMENTAL
Intervention: Active drug therapy (50 mg chlorthalidone, 100 mg chlorthalidone, and 100 mg chlorthalidone plus 0.25 mg reserpine)
Number of subjects: 1000
Study 360921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 30921982 — intervention group
Group type: EXPERIMENTAL
Intervention: Th1-transforaminal epidural injection (Th1-TFEI)
Number of subjects: 30